Surveillance of HFMD in Pediatric Outpatients
Recruiting
Observational Study
Hand, Foot and Mouth Disease
Herpangina
Enterovirus Infections
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 10
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aims of this prospective multicentric study is to determine the types of enteroviruses (EVs) responsible for hand, foot and mouth disease (HFMD) or herpangina in children seen within an ambulatory setting :
* to detect an EV-A71 epidemic or another type associated with atypical forms of the disease at an early stage
* to describe and compare the epidemiological, demographic, clinical and viro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children aged 0 to 10 years presenting with HFMD or herpangina
Exclusion Criteria:
* Refusal to participate by holders of parental authority
* Refusal to participate for children over 3 years of age
Contacts